Hot Natural Products & Bioactive Compounds

BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.

Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.

Hot Products from BioCrick

Showing 8985 - 8992 of 9359 hot products

BioCrick hot natural products and bioactive compounds
Catalog No. Product Name
BCN8050 Mesopsin
1. Mesopsin has antioxidant activity.
BCN8052 Salannin
1. Salannin inhibits ecdysone 20-monooxygenase (E-20-M) activity in a dose-dependent fashion.
2. Salannin has antifeedant and insect growth-regulating activities .
3. Salannin has anti-inflammatory activity,it exerts moderate inhibition (IC(50) values of 410-471 mol ratio/32 pmol TPA) of TPA-induced Epstein-Barr virus early antigen (EBV-EA) activation in Raji cells.
BCN8053 Nimbolide
1. Nimbolide is a more potent antiproliferative and apoptosis inducing agent and offers promise as a candidate agent in multitargeted prevention and treatment of cancer.
2. Nimbolide can sensitize tumor cells to chemotherapeutic agents through interaction with IKK, leading to inhibition of NF-κB-regulated proteins.
3. Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.
4. Nimbolide attenuates the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes.
5. Nimbolide has antibacterial potential .
BCN8057 Zeylasterone
1. Zeylasterone shows bactericidal activity.
BCN8062 Magnoloside D
1. Magnoloside D shows moderate cytotoxicity against MGC-803 and HepG2 cells.
2. Magnoloside D shows potent antioxidant capacity.
BCN8063 Podophyllotoxinone
1. Podophyllotoxinone shows inhibitory activity against L1210 leukemia and KB cells in vitro.
BCN8066 Diphyllin
1. Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.
2. Diphyllin has in vitro antileishmanial activity, it exerts a strong specific inhibitory activity (IC50 = 0.2 microM) resulting from the inhibition of parasite internalization within macrophages.
3. Diphyllin has anti-inflammatory activities, it shows 50% inhibition of NO production from peritoneal macrophages.
BCN8067 Cudraflavone B
1. Cudraflavone B has anti-proliferative activity, mouse brain monoamine oxidase (MAO) inhibitory effects, apoptotic actions in human gastric carcinoma cells and mouse melanoma cells, and hepatoprotective activity.
2. Cudraflavone B may be a lead for the development of a potential candidate for human oral squamous cell carcinoma cells.